Clinical trial

Comparison Between Technosphere/Insulin Inhalation Powder Versus Rapid Acting Insulin in Subjects With Type 2 Diabetes Mellitus

NCT00539890

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2005-11-01

PhasePHASE3

Study timeline

Study start (unknown)2005-11-01Date precision: month

Registry last updated2009-10-14

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Type 2unresolved

Interventions

Technosphere InsulinDRUG

Sponsors & collaborators

Mannkind Corporationlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00539890 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.